saeid-mordechai-nosrati
Saeid Mordechai Nosrati, MD
Associate Professor of Medicine
  • University of Southern California
    Los Angeles, California, USA
    Phone: (213) 804 5096, Fax: (323) 983-9400
    E-mail: nosrati@usc.edu


Education

DEGREE DEPARTMENT UNIVERSITY YEAR
  Chemistry CUNY, Brooklyn College, New York. 1983
M.D   SUNY, Downstate School of Medicine, Health Science, Center At Brooklyn 1987
Internship Internal Medicine Albert Einstein School of Medicine, Montefiore Medical Center, Bronx, New York. 1987–1988
Residency Internal Medicine Albert Einstein School of Medicine, Montefiore Medical Center, Bronx, New York. 1988–1990
Fellowship Nephrology Harvard Medical School, Beth Israel Hospital, Boston, MA 1990–1991
Fellowship Nephrology Harvard Medical School 1991–1992
NIH Sponsored Nephrology Research, Beth Israel, Hospital, Boston
Research Fellow Transplant Nephrology Beth Israel Hospital Harvard Medical School Boston, MA 1990-1992

Biography

Dr. Nosrati attended medical school at the State University of New York in Brooklyn (1983-1987). After completing an internship and residency program at the Albert Einstein School of Medicine, Bronx, NY,(1987-2000), Dr. Nosrati was awarded a nephrology fellowship at Beth Israel Hospital/ Harvard Medical School in Boston, MA. After completing his fellowship, Dr. Nosrati joined the Keck-USC School of Medicine in Los Angeles, CA in 1992 as an Assistant Professor of Medicine. He is currently an Associate Professor of Medicine at Keck-USC School of Medicine in Los Angeles, CA. and Medical Director of the CKD program and the Renal, Hypertension and Transplant Clinic at the LAC+USC. Dr. Nosrati has also served as Medical Director of the Peritoneal Dialysis Program and Home Hemodialysis Program at the USC Dialysis Center and has been an attending physician at the CAPD Clinic, USC Outpatient Dialysis, Medicine Ward and Renal Ward at the LAC+USC Medical Center. Dr. Nosrati is actively involved in a number of bench research as well as clinical research activities spanning different fields. Dr. Nosrati is actively conducting research in advancing kidney dialysis, liver dialysis and providing a support system for the MOF/MODS multisystem failures using advanced technologies. In addition he has been actively conducting major pharmaceutical sponsored phase II-IV clinical trials in hypertension, anemia, iron, secondary hyperparathyroidism etc.


Research Interest

  • Chronic Renal Disease
  • Disorders of Lipoid Metabolism
  • Hypertension (HTN)
  • Vitamin D Deficiency

Scientific activities

Employment History
1999–Present Associate Professor of Medicine, Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
1992–Present Assistant Professor of Medicine, Keck School of Medicine, University of Southern
California, Los Angeles, CA, USA
1992 – Present Medical Director OF Nephrology, Hypertension, CKD and Renal Transplant Clinic
LAC/USC at  H. Claude Hudson Comprehensive Center, USA
  Medical Director of Home Dialysis & Peritoneal Dialysis Program
Professional Activities

Memberships

  • American Medical Association, 1992
  • American College of Physicians, 1992
  • American Society of Nephrology, 1992
  • American Society of Transplant Physicians, 1992
  • National Kidney Foundation, 1992
  • Renal Physician Association, 1992

Medical and Advisory Board Memberships.

  • National Kidney Foundation -Scientific Advisory Board
  • Member of Medical Advisory Board -People Assisting The Homeless (PATH) 1999-2003
  • Member of Scientific Advisory Board -University Kidney Disease Research Association 2002-present
  • Fabry’s Disease Medical Consultant -2002-present
  • Member of Scientific Advisory Board Archinoetics LLC  iHAT - intelligent Human Assistive Technology  2005-2007
HONORS AND AWARDS

Teleconference

  • GlaxoSmithKline
    Renal Considerations When Treating Patients with HIV 12/15/2006
  • GlaxoSmithKline
    HIV Nephropathy and Renal Failure: Renal Considerations in HIV treatment
    12/19/2006

Publications

  1. Ye S, Nosrati S.M., Campese VM: Nitric oxide modulates the neurogenic control of blood pressure in rats with chronic renal failure. J Clin Invest 99:540-548, 1997.
  2. Nosrati S.M., Khawaja S, El-Shahawy M, Massry SG: Effect of angiotensin converting enzyme inhibition by perindopril on proteinuria of primary renal diseases. Am J Nephrology 17:511-517, 1997.
  3. Campese VM, Nosrati S.M.: Diagnosis and evaluation of secondary hypertension. Clinical Cornerstone Hypertension 2:27-40, 1999.
  4. Madkour H, Ali K, Nosrati S. M., Massry SG: Efficacious response with low-dose indapamide therapy in the treatment of Type II diabetic patients with normal renal function or moderate renal insufficiency and moderate hypertension. Am J Nephrol 22:2–5, 2002.
  5. Bemanian S, Motallebi M, Nosrati S.M.: Cocaine-induced renal infarction: report of a case and review of the literature. BMC Nephrol 6:10, 2005.
  6. Hatim Husain, Ajaz Bulbul, Abid Rizvi, Dan Douer, Nosrati S.M. :Membranous Glomerulonephritis as a paraneoplastic Marker of Myelodysplastic Syndrome. (Abstract Presentation Acp 2008).

Books

  1. Mordechai Saeid Nosrati MD: The Diet of L.O.V.E. (iUniverse Publishing) USA. (Published April 2016)
  2. Mordechai Saeid Nosrati MD: The Book of Genesis in Language of Science (Tate Publishing) USA.(in Progress)
  3. Mordechai Saeid Nosrati MD: Defeating Your Pain Holistically (Tate Publishing) (in Progress)

Lectures

Topic of Lectures in Medical and Renal Grand Rounds, Core Curriculum, lectures for medical students, interns, residents and fellows and faculty at LAC-USC Medical Center and Community Hospitals 1992-2016

i. Lupus Nephritis; Treatment and Complications
ii. Diabetic Nephropathy
iii. HIV Nephropathy
iv. NSAID Nephropathy
v. Renal Artery Stenosis
vi. COX 2 Inhibitors and Renal Issues
vii. Diagnosis and Treatment of Rhabdomyolysis
vii. Diagnosis and Treatment of Hypernatremia
viii. Diagnosis and Treatment of Hyponatremia ix. Proteinuria
x. Nephrotic Syndrome
xi. Central and Extra-Pontine Myelinolysis
xii. Iron Metabolism ( Iron: Friend or Foe )
xiii. CRRT (CVVHD, SCUF, etc.)
xiv. Use of P.E.T. Test in PD Dosing
xv. Membrane Failure
xvi. Renal Consideration When Treating Patients With HIV Disease
xvii. Euvolemic Hyponatremia and AVP Antagonism with Vaprisol
xviii. Hypervolemic Hyponatremia and AVP Antagonism with Conivaptan HCl
xix. PD Controversies xx. Adequacy in PD
xxi. Iron: Friend or Foe
xxii. Parenteral Nutrition in Critically Ill Patients
xxiii. The Importance of Residual Renal Function and its preservation
xxiv. Anti GBM / RPGN
xxv. The Omics of Iron; iron Regulation and Metabolism


Autoimmune Journal Flyer